PANCREATIC NEUROENDOCRINE TUMOR
Clinical trials for PANCREATIC NEUROENDOCRINE TUMOR explained in plain language.
Never miss a new study
Get alerted when new PANCREATIC NEUROENDOCRINE TUMOR trials appear
Sign up with your email to follow new studies for PANCREATIC NEUROENDOCRINE TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Hard-to-Treat gut tumors: targeted pill shows promise
Disease control OngoingThis study tests a pill called abemaciclib in 20 adults with advanced digestive neuroendocrine tumors that have spread, cannot be removed by surgery, and no longer respond to standard treatments. The drug works by blocking certain enzymes that help cancer cells grow. The main goa…
Matched conditions: PANCREATIC NEUROENDOCRINE TUMOR
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated May 17, 2026 02:07 UTC
-
New pill shows promise for slowing rare cancers
Disease control OngoingThis study tests an experimental drug called CVM-1118 in 34 people with advanced neuroendocrine tumors that have not responded to standard treatments. The goal is to see if the drug can slow tumor growth or shrink tumors. Participants take the drug by mouth, and their progress is…
Matched conditions: PANCREATIC NEUROENDOCRINE TUMOR
Phase: PHASE2 • Sponsor: TaiRx, Inc. • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
New drug cocktail offers hope for rare cancers
Disease control OngoingThis study tests a combination of two drugs, atezolizumab and bevacizumab, in people with rare solid tumors that are hard to treat. The goal is to see if the drugs can shrink or control the cancer by boosting the immune system and blocking tumor blood supply. About 133 adults wit…
Matched conditions: PANCREATIC NEUROENDOCRINE TUMOR
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 11, 2026 20:50 UTC
-
New marker may predict pancreatic tumor aggressiveness
Knowledge-focused OngoingThis study is for 100 adults with non-functional pancreatic neuroendocrine tumors (NF-pNETs). Researchers want to see if two markers, called ATRX and DAXX, found in biopsy samples taken during an endoscopic ultrasound, can help predict how aggressive the tumor is. The goal is to …
Matched conditions: PANCREATIC NEUROENDOCRINE TUMOR
Sponsor: Azienda Ospedaliera Universitaria Integrata Verona • Aim: Knowledge-focused
Last updated May 15, 2026 11:55 UTC